Literature DB >> 27312074

The treatment of epilepsy in pregnancy: The neurodevelopmental risks associated with exposure to antiepileptic drugs.

R Bromley1.   

Abstract

A number of antiepileptic drugs (AEDs) have been confirmed as teratogens due to their association with an increased malformation rate. The majority of research to date does not find an association between prenatal exposure to monotherapy carbamazepine, lamotrigine or phenytoin and neurodevelopmental outcome in comparison to control children and noted higher abilities in comparison to children exposed to valproate; but further work is needed before conclusions can be drawn. Data for levetiracetam was limited to one study, as was the evidence for topiramate. Sodium valproate exposure appeared to carry a dose dependent risk to the developing brain, with evidence of reduced levels of IQ, poorer verbal abilities and increased rate of autistic spectrum disorder both in comparison to control children and children exposed to other AEDs. The severity of the neurodevelopmental deficits associated with prenatal exposure to valproate highlight the critical need to consider neurodevelopmental outcomes as a central aspect of teratological research.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-epileptic drugs; Epilepsy; Neurodevelopment; Pregnancy; Teratology

Mesh:

Substances:

Year:  2016        PMID: 27312074     DOI: 10.1016/j.reprotox.2016.06.007

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  7 in total

1.  Familial Liability to Epilepsy and Attention-Deficit/Hyperactivity Disorder: A Nationwide Cohort Study.

Authors:  Isabell Brikell; Laura Ghirardi; Brian M D'Onofrio; David W Dunn; Catarina Almqvist; Søren Dalsgaard; Ralf Kuja-Halkola; Henrik Larsson
Journal:  Biol Psychiatry       Date:  2017-08-12       Impact factor: 13.382

Review 2.  Research Progress on the Role of Vitamin D in Autism Spectrum Disorder.

Authors:  Jing Wang; Haoyu Huang; Chunming Liu; Yangping Zhang; Wenjuan Wang; Zhuo Zou; Lei Yang; Xuemei He; Jinting Wu; Jing Ma; Yun Liu
Journal:  Front Behav Neurosci       Date:  2022-05-10       Impact factor: 3.617

3.  Prenatal exposure to antiepileptic drugs and use of primary healthcare during childhood: a population-based cohort study in Denmark.

Authors:  Anne Mette Würtz; Dorte Rytter; Claus Høstrup Vestergaard; Jakob Christensen; Mogens Vestergaard; Bodil Hammer Bech
Journal:  BMJ Open       Date:  2017-01-05       Impact factor: 2.692

4.  Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.

Authors:  Jakob Christensen; Lars Pedersen; Yuelian Sun; Julie Werenberg Dreier; Isabell Brikell; Søren Dalsgaard
Journal:  JAMA Netw Open       Date:  2019-01-04

Review 5.  Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy.

Authors:  Diogo M Lourenço; Leonor Ribeiro-Rodrigues; Ana M Sebastião; Maria J Diógenes; Sara Xapelli
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

6.  How 25(OH)D Levels during Pregnancy Affect Prevalence of Autism in Children: Systematic Review.

Authors:  Nazlı Uçar; William B Grant; Isabel Peraita-Costa; María Morales Suárez-Varela
Journal:  Nutrients       Date:  2020-07-31       Impact factor: 5.717

7.  Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa.

Authors:  Ushma Mehta; Mariette Smith; Emma Kalk; Helen Hayes; Annoesjka Swart; Lawrence Tucker; Renier Coetzee; Andrew Boulle; Marc Blockman
Journal:  Drug Saf       Date:  2021-01       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.